Ching-Yi Chuo

Ching-Yi (James) Chuo, PhD, MSPH, serves as the RWE Generation Associate Director at Gilead Sciences, leading real-world evidence strategies and analytics for HIV and cancer-related projects. Ching-Yi has a diverse professional background, including roles as a Data Scientist at Genentech, where contributions supported over five molecules and involved extensive collaboration across functional teams. Previous experience includes a Data Analyst position at the U.S. Department of Veterans Affairs, focusing on cancer risk assessments for HBV patients, and an Internship at Shell, conducting epidemiological studies. Academic qualifications include a PhD in Epidemiology and Biostatistics from UTHealth Houston and a Master’s in Global Epidemiology from Emory University.